scholarly journals Pathological Role of Apelin in Angiogenic Eye Disease

2011 ◽  
Vol 131 (8) ◽  
pp. 1201-1206 ◽  
Author(s):  
Atsushi KASAI
Keyword(s):  
2018 ◽  
Vol 16 (4) ◽  
pp. 470-477 ◽  
Author(s):  
Xuhua Tan ◽  
Yihe Chen ◽  
William Foulsham ◽  
Afsaneh Amouzegar ◽  
Takenori Inomata ◽  
...  

2019 ◽  
Vol 50 (1) ◽  
pp. 3-8 ◽  
Author(s):  
Ritika Mukhija ◽  
Amar Pujari ◽  
Rashmi Singh ◽  
Shreya Nayak ◽  
Vipul Singh ◽  
...  

We sought to evaluate the role and diagnostic potential of ocular B-scan ultrasonography in childhood eye disease in an observational cross-sectional study; 1091 patients with a total of 1445 eyes examined were studied. Cataract was the single most common indication for ultrasound followed by corneal pathology, ocular trauma, posterior segment pathology, primary congenital glaucoma, leukocoria, orbital pathology and other disease. Ultrasonography resulted in a change in diagnosis in 198 cases (18%). We conclude that B-scan ultrasonography plays an important adjunctive role in the management of childhood eye disease.


Cornea ◽  
2009 ◽  
Vol 28 (Suppl 1) ◽  
pp. S70-S74 ◽  
Author(s):  
Murat Dogru ◽  
Tais Wakamatsu ◽  
Takashi Kojima ◽  
Yukihiro Matsumoto ◽  
Tetsuya Kawakita ◽  
...  

2005 ◽  
Vol 51 ◽  
pp. 1-13 ◽  
Author(s):  
Philip J. Luthert ◽  
Cynthia Medford Langley

Norman Ashton, the first ophthalmic pathologist in the UK, spent his career furthering the understanding and treatment of eye disease and exercising the political acumen to garner the funding necessary to advance this new field. His demonstration of the obliteration of growing retinal endothelial cells caused by the excessive administration of oxygen in premature infants is perhaps his best–known work. Apart from this, his casts of the choroidal and trabecular meshwork circulation and Schlemm's canal were the first to display the exact anatomy of these structures to the ophthalmic community. Studies of the pathogenesis of cotton wool spots, neovascularization and microaneurysms and the behaviour of retinal vessels contributed lastingly to the understanding of retinal vascular disease. With associates he demonstrated the role of the endothelium in the blood–retina barrier. Investigation of diabetic, hypertensive and other retinopathies provided fundamental contributions to the comprehension of these conditions. Original studies established an insight into amoebic ocular infections, ocular toxocariasis, nosematosis and a collection of eye diseases in animals and fish. Fight for Sight and the European Ophthalmic Pathological Society owe their beginnings, in large part, to his foresight and energy. He is remembered as a worthy researcher, a witty speaker, a respected supervisor and a kind man.


Thyroid ◽  
1998 ◽  
Vol 8 (6) ◽  
pp. 553-556 ◽  
Author(s):  
KAZUAKI GUNJI ◽  
SUMIHARA KUBOTA ◽  
JIL SWANSON ◽  
JACEK KILJANSKI ◽  
TOMASZ BEDNARCZUK ◽  
...  

2012 ◽  
Vol 2012 ◽  
pp. 1-8 ◽  
Author(s):  
Frederick T. Fraunfelder ◽  
James J. Sciubba ◽  
William D. Mathers

The purpose of this paper is to review the possible role of polypharmacy in causing dry eye disease (DED), reflecting the complex interactions and complications associated with the use of multiple systemic and topical ocular medications. The pharmacological, physiological, anatomical, and histological mechanisms causing dry mouth differ little from those causing dry eye. Oral polypharmacy is the most common cause of dry mouth, but has not been investigated as a cause of dry eye. Topical ocular polypharmacy has been shown to cause DED. Information on drugs that likely cause or aggravate DED and the controversial role of preservatives in topical ocular medications are examined. Systemic or topical ocular medications and preservatives used in topical ocular drugs may cause dry eye through the drug's therapeutic action, ocular surface effects, or preservatives, and the effects probably are additive. Long-term use of topical ocular medications, especially those containing preservatives such as BAK, may play an important role in DED and the role of polypharmacy needs further study. We review possible ways to decrease the risk of medication-related dry eye.


Sign in / Sign up

Export Citation Format

Share Document